| 151 |
Phospholipids and L-Carnitine Screening in Children with Congenital Heart Diseases Undergoing Surgical Correction
|
2018 |
| 152 |
Phospholipids and L-Carnitine Screening in Children with Congenital Heart Diseases Undergoing Surgical Correction
|
2018 |
| 153 |
Phospholipids and L-Carnitine Screening in Children with Congenital Heart Diseases Undergoing Surgical Correction |
2018 |
| 154 |
Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: Impact of HIF-1α-VEGF signaling pathway
|
2018 |
| 155 |
Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: Impact of HIF-1α-VEGF signaling pathway
|
2018 |
| 156 |
Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: Impact of HIF-1α-VEGF signaling pathway
|
2018 |
| 157 |
Role ofmiRNA-210, miRNA-21 andmiRNA-126 asdiagnostic biomarkers incolorectal carcinoma: impact ofHIF-1α-VEGF signaling pathway |
2018 |
| 158 |
Serum levels of psoriasin (S100A7) and koebnerisin (S100A15) as potential markers of atherosclerosis in patients with psoriasis. |
2018 |
| 159 |
Serum selenium level in acute myocardial infarction
|
2018 |
| 160 |
Studying the frequency of aberrant DNA methylation of APC, P14, and E-cadherin genes in HCV-related hepatocarcinogenesis. |
2018 |